Gelesis Holdings Return on Investment 2021-2022 | GLS
Current and historical return on investment (ROI) values for Gelesis Holdings (GLS) over the last 10 years.
| Gelesis Holdings ROI - Return on Investment Historical Data |
| Date |
TTM Net Income |
LT Investments & Debt |
Return on Investment |
| 2022-09-30 |
$-0.04B |
$0.02B |
89.12% |
| 2022-06-30 |
$-0.05B |
$0.04B |
98.15% |
| 2022-03-31 |
$-0.04B |
$0.04B |
62.15% |
| 2021-12-31 |
$-0.01B |
$-0.30B |
17.63% |
| 2021-06-30 |
$-0.04B |
|
inf% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.012B |
$0.011B |
|
Gelesis is a consumer-centered biotherapeutics company advancing a novel category of treatments for weight management and gut related chronic diseases. Gelesis, formerly known as Capstar Special Purpose Acquisition Corp., is based in BOSTON.
|
